Long-term follow-up of cryosurgery of basal cell carcinoma of the eyelid

doi:10.1016/S0190-9622(97)80328-3

Journal of the American Academy of Dermatology

Volume 36, Issue 5, May 1997, Pages 742-746

https://doi.org/10.1016/S0190-9622(97)80328-3 Get rights and content

Background:

Basal cell carcinoma (BCC) is the most common malignant tumor of the eyelid and its incidence is increasing. It remains to be established which is the best treatment in terms of safety and cost-effectiveness.

Objective:

Our purpose was to analyze the long-term treatment results and possible side effects of cryosurgery of eyelid BCC.

Methods:

During the last 14 years 219 patients (222 tumors) treated for eyelid BCC with cryosurgery were followed up prospectively for up to 10 years.

Results:

The tumors cleared completely after treatment in all patients with no recurrence observed to date. Ninety-two patients were followed up for 5 years or more. Complications were few and minor. In 26 treated eyelids conjunctival overgrowth was noted.

Conclusion:

We conclude that cryosurgery of BCC of the eyelid has a high cure rate, is cost-effective, and is well tolerated.

References (11)

MargoC.E. et al.
Basal cell carcinomas of the eyelid and periocular skin
Surv Ophthalmol
(1993)
KuflikE.G. et al.
The five-year cure rate achieved by cryosurgery for skin cancer
J Am Acad Dermatol
(1991)
FraunfelderF.T. et al.
Results of cryotherapy for eyelid malignancies
Am J Ophthalmol
(1984)
SilvermanM.K. et al.
Recurrence rates of treated basal cell carcinomas. Part 1: Overview
J Dermatol Surg Oncol
(1991)
BeardC. et al.
Prospective views in the treatment of eyelid and adnexal malignancies
Ophthalmic Surg
(1978)

There are more references available in the full text version of this article.

Cited by (51)

Postoncological lacrimal duct reconstruction: A practical classification system for reconstructive planning and short-term results of a case series
2018, Journal of Plastic, Reconstructive and Aesthetic Surgery
Citation Excerpt :
Medial canthal tumors rarely involve the lacrimal duct.6–9 The current treatment standard is surgical excision until tumor-free margins are achieved using various modalities.4,5,10–12 Irradical resections lead to recurrence rates up to 25.4%.13,14
Surgical resection of skin tumors in the medial canthal area may damage the lacrimal duct and can result in chronic epiphora. Postoncologic reconstruction of the lacrimal duct has not been studied extensively. The current study discusses the anatomical and functional features of the lacrimal duct. It describes short-term functional outcomes after monocanalicular reconstruction of the lacrimal duct in a case series of 10 patients.
From February 2015 to October 2017, all patients with a postoncological lacrimal duct defect were analyzed to make an anatomical classification. The functional outcomes of patients after monocanalicular reconstruction were measured with the Munk scale up to 3 months after stent removal.
Twelve patients had lacrimal duct defects after Mohs resection. Anatomical characteristics were used to create a clinical classification for lacrimal duct defects. This classification divides the upper (U) and lower (L) proximal lacrimal duct into two sections which can be damaged: the punctum and pars verticalis (1), the canaliculus horizontalis (2), or combined (3). The Common lacrimal duct (C) is the distal part of the lacrimal duct and can also be affected. Ten patients were analyzed after lacrimal duct reconstruction. Three months after stent removal, none of the patients suffered from epiphora.
This article proposes an anatomical classification for lacrimal duct defects in the proximal lacrimal drainage system. The classification can be applied in comparing cases and determining reconstructive strategies after oncologic skin tumor resection. Short-term results are promising for future efforts to reconstruct the lacrimal duct.
Cryosurgery for Tumors
2007, Journal of the American College of Surgeons
Citation Excerpt :
Basal cell carcinomas of the eyelids require special mention. A high rate of cure, commonly better than 95% after longterm followup, is cited in several reports.53-56 Lindgren and Larko55 had no recurrences in 219 patients.
Basal cell carcinoma
2007, Clinical Ophthalmic Oncology with CD-ROM
Basal Cell Carcinoma
2007, Clinical Ophthalmic Oncology
Head and Neck Skin Cancer
2022, Peterson's Principles of Oral and Maxillofacial Surgery, Fourth Edition
Eyelid basal cell carcinoma classification using shallow and deep learning artificial neural networks
2021, Evolving Systems

View all citing articles on Scopus

View full text

Long-term follow-up of cryosurgery of basal cell carcinoma of the eyelid

Background:

Objective:

Methods:

Results:

Conclusion:

Surv Ophthalmol

J Am Acad Dermatol

Am J Ophthalmol

Recurrence rates of treated basal cell carcinomas. Part 1: Overview

J Dermatol Surg Oncol

Prospective views in the treatment of eyelid and adnexal malignancies

Ophthalmic Surg